Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis | Synapse

September 21, 2015Open Access

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

MAMatthew J. ArmstrongQueen Elizabeth University Hospital DHDiana HullUniversity Hospitals Birmingham NHS Foundation Trust KGKathy GuoHospital of the University of Pennsylvania

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Liraglutide reduces metabolic dysfunction, insulin resistance and lipotoxicity in the key metabolic organs in the pathogenesis of NASH. Liraglutide may offer the potential for a disease-modifying intervention in NASH.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Armstrong et al. (Mon,) studied this question.

synapsesocial.com/papers/69dd61d8ae7c4d5b291011e8 https://doi.org/https://doi.org/10.1016/j.jhep.2015.08.038

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo